Drug Type Small molecule drug |
Synonyms |
Mechanism ALK inhibitors(Anaplastic lymphoma kinase inhibitors), DDR2 inhibitors(Discoidin domain-containing receptor 2 inhibitors), NTRK inhibitors(Neurotrophic tyrosine kinase receptor inhibitors) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | IT | - |